89bio stock rallies 40% amid data for rival MASH drug 89bio stock rallies 40% amid data for rival MASH drug Post Contentetnb, akro, mdglRead More You might also be interested in reading P2P platform for BCH?. January 27, 2025 In Mainstream ← Previous post Next post →